Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma

Front Genet. 2022 Aug 17:13:961153. doi: 10.3389/fgene.2022.961153. eCollection 2022.

Authors

Sibin Zhang¹, Xu Xiao¹, Yu Wang², Tianjun Song³, Chenlong Li¹, Hongbo Bao¹, Qing Liu¹, Guiyin Sun¹, Xiaoyang Sun¹, Tianqi Su¹, Tianjiao Fu¹, Yujie Wang¹, Peng Liang¹

Affiliations

¹ Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China.
² Department of Esophageal Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
³ Department of Medicine II, University Hospital LMU Munich, Munich, Germany.

Abstract

[This corrects the article DOI: 10.3389/fgene.2022.899125.].

Keywords: bioinformatics signature; glioma; immune enviroment; immunetherapy; prognosis.

Copyright © 2022 Zhang, Xiao, Wang, Song, Li, Bao, Liu, Sun, Sun, Su, Fu, Wang and Liang.

Publication types

Published Erratum